詳細情報

BACK

著作分類 IIRワーキングペーパー
著者 Wan, Yunyun(Jiangyun) : Kaz Miyagiwa
論文タイトル Pharmaceutical patents and generic entry competition: A New View on the Hatch-Waxman Act
機関名 一橋大学イノベーション研究センター
ナンバー WP#15-18
公開日 2015/08/25
要旨 This paper presents a model of generic entry competition that captures salient features of the Hatch-Waxman Act, enacted with two incompaible objectives of restoring incentives for new drug development and stimulating generic competition. For the latter objective, Hatch-Waxman eases FDA approval procedures for generics, and encourages patent challenges by granting marketing exclusivity rights to the first patent challenger. We show that the two entry-promoting measures complement each other in restoring innovative incentives. While branded and generic drug manufacturers’ interests are opposed in general, there are cases in which they all benefit from marketing exclusivity. The welfare implications are also examined. Revised in July 2016
備考 Revised in July 2016
参考URL
ラベル 経済学
登録日 2015/08/25

PDF DOWNLOAD

BACK